Elsevier

Vaccine

Volume 36, Issue 32, Part A, 6 August 2018, Pages 4761-4767
Vaccine

Status of HPV vaccine introduction and barriers to country uptake

https://doi.org/10.1016/j.vaccine.2018.02.003Get rights and content
Under a Creative Commons license
open access

Abstract

During the last 12 years, over 80 countries have introduced national HPV vaccination programs. The majority of these countries are high or upper-middle income countries. The barriers to HPV vaccine introduction remain greatest in those countries with the highest burden of cervical cancer and the most need for vaccination. Innovation and global leadership is required to increase and sustain introductions in low income and lower-middle income countries.

Keywords

HPV
Vaccine
Human papillomavirus
Low income countries
Uptake

Cited by (0)